Cómo Crear PNTs a Prueba de Auditorías: La Lista de Verificación Definitiva de QA

Escribir un Procedimiento Normalizado de Trabajo (PNT / SOP) no es solo plasmar palabras en un papel; es construir un escudo de cumplimiento para tu planta. Un PNT mal redactado es la causa directa de desviaciones, errores humanos y dolores de cabeza durante las auditorías de la #MHRA o la #FDA. 🛡️Ya sea que estés redactando un procedimiento desde cero o revisando una actualización, aquí…

https://www.frontlifesciences.com/como-crear-pnts-a-prueba-de-auditorias-la-lista-de-verificacion-definitiva-de-qa/

MHRA to offer early review of non-animal data. The Medicines and Healthcare products Regulatory Agency (MHRA) will offer early review of non-animal data in a decision supporting the government’s strategy to reduce animal testing in drug development.

The move is intended to help drug developers make greater use of New Approach Methodologies (NAMs),
https://www.ddw-online.com/mhra-to-offer-early-review-of-non-animal-data-41080-202603/

#Animaltesting
#MHRA #Science
#Newapproachmethodologies #nams
#Regulatory #videnskab #dyreforsøg

Side effects wrongly listed as "uncommon" in a Parkison's medication.

The Chair of the Commons Health Select Committee is not happy and wants government action against the UK's drug safety regulator, the MHRA.

https://www.bbc.co.uk/news/articles/ckg0xxwn041o

#MHRA #Pharma #Medicine #NHS

UK Medical Regulator Stops Children’s Puberty Blocker Study Over Safety Concerns

UK medical study on puberty blockers for children paused by MHRA due to safety concerns. Study researchers to meet next week. Who is affected?

#PubertyBlockers, #UKHealth, #MedicalStudy, #ChildSafety, #MHRA

https://newsletter.tf/uk-pauses-childrens-puberty-blocker-study-over-safety-concerns/

The UK's Pathways study on puberty blockers for children has been paused. The regulator MHRA has serious safety worries, especially about the minimum age for participants.

#PubertyBlockers, #UKHealth, #MedicalStudy, #ChildSafety, #MHRA

https://newsletter.tf/uk-pauses-childrens-puberty-blocker-study-over-safety-concerns/

UK Puberty Blocker Trial Paused Amid Regulator's Safety Concerns

UK's Pathways trial for puberty blockers paused by MHRA due to safety concerns. Discusses age limits and future of the trial for young people.

#PubertyBlockers, #UKTrial, #MHRA, #YouthHealth, #GenderIncongruence

https://newsletter.tf/uk-puberty-blocker-trial-paused-due-to-mhra-safety-concerns/

The UK's Pathways trial for puberty blockers has been paused. The regulator, MHRA, has safety concerns, especially about the age limit for participants.

#PubertyBlockers, #UKTrial, #MHRA, #YouthHealth, #GenderIncongruence

https://newsletter.tf/uk-puberty-blocker-trial-paused-due-to-mhra-safety-concerns/

Clinical Trial for Puberty Blockers Paused Amid Regulatory Concerns

A UK clinical trial for puberty blockers for gender incongruence is paused. The MHRA has safety concerns about young participants, especially the minimum age.

#PubertyBlockers, #ClinicalTrial, #MHRA, #ChildSafety, #GenderIncongruence

https://newsletter.tf/uk-puberty-blocker-trial-paused-for-young-people-due-to-safety-worries/

The PATHWAYS trial for puberty blockers in young people is on hold. The MHRA wants to raise the minimum age from 10 to 14 due to safety concerns.

#PubertyBlockers, #ClinicalTrial, #MHRA, #ChildSafety, #GenderIncongruence

https://newsletter.tf/uk-puberty-blocker-trial-paused-for-young-people-due-to-safety-worries/

The MHRA's 'AI Airlock' is apparently hitting warp speed on AI tools for patient care, aiming to slash agonizing wait times for diagnoses. From clinical note-takers to advanced cancer diagnostics, it's all hands on deck.

Just remember, 'it works on my machine' takes on a whole new meaning when dealing with actual humans. What kind of rigorous testing do you think these medical AIs *really* need?

#AIforHealth #DigitalHealth #MHRA #HealthcareAI #TechNews
https://www.artificialintelligence-news.com/news/mhra-fast-tracks-next-wave-of-ai-tools-for-patient-care/